发明名称 UNITARY PHARMACEUTICAL DOSAGE FORM
摘要 In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir DF are provided as a multicomponent unitary oral dosage form, component 1 comprising tenofovir DF (and, optionally, emtricitabine) and component 2 comprising efavirenz, wherein components 1 and 2 are in a stabilizing configuration. In preferred embodiments component 1 is made by dry granulation.
申请公布号 US2017079999(A1) 申请公布日期 2017.03.23
申请号 US201615370588 申请日期 2016.12.06
申请人 BRISTOL-MYERS SQUIBB & GILEAD SCIENCES, LLC 发明人 DAHL Terrence C.;HUSSAIN Munir A.;LIPPER Robert A.;JERZEWSKI Robert L.;MENNING Mark M.;OLIYAI Reza;YANG Taiyin
分类号 A61K31/683 主分类号 A61K31/683
代理机构 代理人
主权项 1. A composition comprising tenofovir DF and a surfactant whereby the surfactant is in a stabilizing configuration with the tenofovir DF.
地址 Foster City CA US